← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1987Last known activity
Jan 5, 2026
Timeline
1980s
- Jan 1, 1986
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)— Founded
Drugs by trial phase (143 distinct, 168 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (57 own, 0 via acquisition)
Phase 1 (28 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Alopecia
- Aortic Arch Syndromes
- Arteritis
- Arthritis
- Arthritis, Experimental
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Reactive
- Arthritis, Rheumatoid
- Arthropathy, Neurogenic
- Atherosclerosis
- Behcet Syndrome
- Bone Diseases
- Bone Diseases, Metabolic
- Bone Resorption
- Breast Neoplasms
- Brucellosis
- Cardiovascular Diseases
- Cellulitis
- Chlamydia Infections
- Colonic Neoplasms
- Connective Tissue Diseases
- Coronary Disease
- Crohn Disease
- Cryopyrin-Associated Periodic Syndromes
- Dermatitis
- Dermatomyositis
- Distal Myopathies
- Down Syndrome
- Eosinophilia
- Epidermolysis Bullosa
- Epidermolysis Bullosa Dystrophica
- Familial Hypophosphatemic Rickets
- Familial Mediterranean Fever
- Femur Head Necrosis
- Fibromyalgia
- Giant Cell Arteritis
- Glomerulonephritis
- Glomerulonephritis, Membranoproliferative
- Glycogen Storage Disease Type II
- Graft vs Host Disease
- Granulomatosis with Polyangiitis
- Heart Diseases
- Hereditary Autoinflammatory Diseases
- Hidradenitis
- Hidradenitis Suppurativa
- Hip Fractures
- Humeral Fractures
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertension
- Hypogonadism
- Hypophosphatemia
- Hypophosphatemia, Familial
- Hypopituitarism
- IgA Vasculitis
- Immune System Diseases
- Infections
- Inflammation
- Insulin Resistance
- Ischemia
- Joint Diseases
- Lung Diseases
- Lung Diseases, Interstitial
- Lupus Erythematosus, Systemic
- Lupus Nephritis
- Mitochondrial Diseases
- Muscular Diseases
- Muscular Dystrophies
- Muscular Dystrophies, Limb-Girdle
- Muscular Dystrophy, Duchenne
- Myalgia
- Myocardial Ischemia
- Myofascial Pain Syndromes
- Myositis
- Necrosis
- Neoplasms
- Nephritis
- Nervous System Malformations
- Neuralgia
- Neuralgia, Postherpetic
- Osteoarthritis
- Osteoarthritis, Knee
- Osteoporosis
- Osteoporosis, Postmenopausal
- Papilledema
- Polyarteritis Nodosa
- Polymyalgia Rheumatica
- Polymyositis
- Prehypertension
- Psoriasis
- Purpura
- Rickets
- Rickets, Hypophosphatemic
- Sarcoglycanopathies
- Sarcopenia
- Sciatica
- Scleroderma, Diffuse
- Scleroderma, Localized
Recent trials (50)
- NCT07242638CollaboratorPhase 2Jan 5, 2026
- NCT07012057Lead sponsorPhase 2Nov 21, 2025
- NCT07012057OfficialPhase 2Nov 21, 2025
- NCT06558188CollaboratorPhase 4Apr 1, 2025
- NCT06721299CollaboratorPhase 1Feb 28, 2025
- NCT06599697CollaboratorPhase 2Jan 1, 2025
- NCT06385275CollaboratorPhase 1/Phase 2Dec 31, 2024
- NCT06750653CollaboratorPhase 4Dec 27, 2024
- NCT06672822CollaboratorPhase 2Dec 1, 2024
- NCT06290713CollaboratorPhase 2Jun 5, 2024
- NCT06234631CollaboratorPhase 2Mar 13, 2024
- NCT06067555CollaboratorEarly Phase 1Dec 31, 2023
- NCT04585711CollaboratorPhase 1Jul 31, 2023
- NCT05900466CollaboratorPhase 2Apr 1, 2023
- NCT05538208CollaboratorPhase 2Jan 31, 2023
Details
- Founded
- Bethesda, MD, US Jan 1, 1986
- Last known activity
- Jan 5, 2026